Botanical species · safety record

Boswellia frereana

The EFSA Compendium of Botanicals holds 6 constituent measurements for Boswellia frereana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Boswellia frereana Birdw.

6Constituent measurements
0Safety records
4Cited sources
37Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 37 licensed products naming Boswellia frereana as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Frankincense, resin
  • Stem resin

What the records describe

Constituents measured

  • 1,8-cineole3
  • Beta-thujone1
  • Myrcene1
  • Verbenone1

Plant parts

  • Aerial part of plants6

Preparations

  • Essential oil3
  • Resin3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleAerial part of plantsResin1.7 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsResin1.18 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil1.9 PercentGC-MSResolve DOI
Beta-thujoneAerial part of plantsEssential oil1.5 PercentGC-MSResolve DOI
VerbenoneAerial part of plantsResin3.1 PercentGC-MSResolve DOI
MyrceneAerial part of plantsEssential oil2.1 PercentGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hamm, S., Bleton, J., Connan, J., Tchapla, A. A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples . Phytochemistry, 2005, vol. 66, no. 12, p. 1499-1514. DOI
  2. Chiavari, G., Galletti, G.C., Piccaglia, R., Mohamud, M.A. Differentiation between resins Boswellia carterii and Boswellia frereana (Frankincense) of Somali origin. Journal of essential oil research, 1991, vol. 3, no. 3, p. 185-186. DOI
  3. Van Vuuren, S. F., Kamatou, G. P. P., Viljoen, A. M. Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples. South african journal of botany, 2010, vol. 76, no. 4, p. 686-691.
  4. Niebler, J., Buettner, A. Frankincense Revisited, Part I: Comparative Analysis of Volatiles in Commercially Relevant Boswellia Species. Chemistry and biodiversity, 2016, vol. 13, no. 5, p. 613-629. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue